The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer

被引：11

作者：

Alonso, Salvador ^{[1
]}

Saltz, Leonard ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[2] Weill Cornell Med, Dept Med, New York, NY USA

来源：

ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / 02期

关键词：

METASTATIC COLORECTAL-CANCER; OXALIPLATIN-BASED CHEMOTHERAPY; FLUOROURACIL PLUS LEUCOVORIN; MISMATCH REPAIR STATUS; STAGE-II; ADJUVANT CHEMOTHERAPY; PHASE-III; 1ST-LINE TREATMENT; THERAPY; SURVIVAL;

D O I：

10.1245/s10434-020-09375-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Micrometastatic disease that is present at the time of surgery is responsible for the overwhelming majority of deaths in patients with what is otherwise perceived to be local and regional colon cancer. The goal of perioperative therapy is to eliminate microscopic residual disease that would otherwise be left behind following surgery. A secondary goal specific to neoadjuvant (preoperative) therapy is to downstage tumors deemed potentially not amenable to an R0 resection on the basis of a suspected T4b primary (locally invading into a surrounding structure). In this landmark series paper, we review the current standard for perioperative therapy in patients with colon cancer.

引用

页码：995 / 1001

页数：7

共 41 条

[11] Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer [J].

Erlichman, C ;

O'Connell, M ;

Kahn, M ;

Marsoni, S ;

Torri, V ;

Tardio, B ;

Zaniboni, A ;

Pancera, G ;

Martignoni, G ;

Labianca, R ;

Barni, A ;

Seitz, JF ;

Milan, C ;

Bedenne, L ;

Giovannini, M ;

Letreut, YP ;

Skillings, J ;

Shepard, L ;

Zee, B ;

Petrioli, R ;

Francini, G .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1356-1363

[12] Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer [J].

Gao, Shanwu ;

Tibiche, Chabane ;

Zou, Jinfeng ;

Zaman, Naif ;

Trifiro, Mark ;

O'Connor-McCourt, Maureen ;

Wang, Edwin .

JAMA ONCOLOGY, 2016, 2 (01) :37-45

[13] Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study [J].

Gray, Richard ;

Barnwell, Jennifer ;

McConkey, Christopher ;

Hills, Robert K. ;

Williams, Norman S. ;

Kerr, David J. .

LANCET, 2007, 370 (9604) :2020-2029

[14] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer [J].

Grothey, A. ;

Sobrero, A. F. ;

Shields, A. F. ;

Yoshino, T. ;

Paul, J. ;

Taieb, J. ;

Souglakos, J. ;

Shi, Q. ;

Kerr, R. ;

Labianca, R. ;

Meyerhardt, J. A. ;

Vernerey, D. ;

Yamanaka, T. ;

Boukovinas, I. ;

Meyers, J. P. ;

Renfro, L. A. ;

Niedzwiecki, D. ;

Watanabe, T. ;

Torri, V. ;

Saunders, M. ;

Sargent, D. J. ;

Andre, T. ;

Iveson, T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) :1177-1188

[15] Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer [J].

Haller, Daniel G. ;

Tabernero, Josep ;

Maroun, Jean ;

de Braud, Filippo ;

Price, Timothy ;

Van Cutsem, Eric ;

Hill, Mark ;

Gilberg, Frank ;

Rittweger, Karen ;

Schmoll, Hans-Joachim .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (11) :1465-1471

[16] Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: Final report of Intergroup 0089 [J].

Haller, DG ;

Catalano, PJ ;

Macdonald, JS ;

O'Rourke, MA ;

Frontiera, MS ;

Jackson, DV ;

Mayer, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8671-8678

[17] Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC). [J].

Iveson, Timothy ;

Sobrero, Alberto F. ;

Yoshino, Takayuki ;

Sougklakos, Ioannis ;

Ou, Fang-Shu ;

Meyers, Jeffery P. ;

Shi, Qian ;

Saunders, Mark P. ;

Labianca, Roberto ;

Yamanaka, Takeharu ;

Boukovinas, Ioannis ;

Hollander, Niels Henrik ;

Torri, Valter ;

Yamazaki, Kentaro ;

Georgoulias, Vassilis ;

Lonardi, Sara ;

Harkin, Andrea ;

Rosati, Gerardo ;

Paul, James .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[18] Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22) [J].

Karoui, M. ;

Rullier, A. ;

Piessen, G. ;

Legoux, J. L. ;

Barbier, E. ;

De Chaisemartin, C. ;

Lecaille, C. ;

Bouche, O. ;

Ammarguellat, H. ;

Brunetti, F. ;

Prudhomme, M. ;

Regimbeau, J. M. ;

Glehen, O. ;

Lievre, A. ;

Portier, G. ;

Hartwig, J. ;

Goujon, G. ;

Romain, B. ;

Lepage, C. ;

Taieb, J. .

ANNALS OF SURGERY, 2020, 271 (04) :637-645

[19] Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue [J].

Kennedy, Richard D. ;

Bylesjo, Max ;

Kerr, Peter ;

Davison, Timothy ;

Black, Julie M. ;

Kay, Elaine W. ;

Holt, Robert J. ;

Proutski, Vitali ;

Ahdesmaki, Miika ;

Farztdinov, Vadim ;

Goffard, Nicolas ;

Hey, Peter ;

McDyer, Fionnuala ;

Mulligan, Karl ;

Mussen, Julie ;

O'Brien, Eamonn ;

Oliver, Gavin ;

Walker, Steven M. ;

Mulligan, Jude M. ;

Wilson, Claire ;

Winter, Andreas ;

O'Donoghue, Diarmuid ;

Mulcahy, Hugh ;

O'Sullivan, Jacintha ;

Sheahan, Kieran ;

Hyland, John ;

Dhir, Rajiv ;

Bathe, Oliver F. ;

Winqvist, Ola ;

Manne, Upender ;

Shanmugam, Chandrakumar ;

Ramaswamy, Sridhar ;

Leon, Eduardo J. ;

Smith, William I., Jr. ;

McDermott, Ultan ;

Wilson, Richard H. ;

Longley, Daniel ;

Marshall, John ;

Cummins, Robert ;

Sargent, Daniel J. ;

Johnston, Patrick G. ;

Harkin, D. Paul .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (35) :4620-4626

[20] Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07 [J].

Kuebler, J. Philip ;

Wieand, H. Samuel ;

O'Connell, Michael J. ;

Smith, Roy E. ;

Colangelo, Linda H. ;

Yothers, Greg ;

Petrelli, Nicholas J. ;

Findlay, Michael P. ;

Seay, Thomas E. ;

Atkins, James N. ;

Zapas, John L. ;

Goodwin, J. Wendall ;

Fehrenbacher, Louis ;

Ramanathan, Ramesh K. ;

Conley, Barbara A. ;

Flynn, Patrick J. ;

Soori, Gamini ;

Colman, Lauren K. ;

Levine, Edward A. ;

Lanier, Keith S. ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) :2198-2204

← 1 2 3 4 5 →